Acute Limb Ischaemia (ALI) Management With 'Indigo' Mechanical Aspiration System

NCT ID: NCT03295539

Last Updated: 2017-10-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-01

Study Completion Date

2019-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

International Multi-Centre registry recording comprehensive data on the use of 'Indigo' Mechanical thrombectomy system by Penumbra Inc for the removal of acute clot causing acute or critical limb ischaemia.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A detailed registry has been designed and approved to be used world wide in vascular and trauma centres, already providing endovascular service for the management of critical limb ischaemia (CLI).

Recent campaigns have shown little is done to improve flow to the lower limbs (legs) of patients to avoid amputation rates. During this time many devises have been used and available on the market. The 'Indigo' system by Penumbra was originally designed from the acute stroke system "ACE". Similar principles were applied in designing the 'Indigo' system. This is currently being used in many centres to manage acute clot causing lower limb ischaemia, however no official registry or international clinical trial has been done to show its significance in managing this disease.

The investigator groups, have created this to come up with enough data to evaluate the Indigo system in the management of (ALI) and offer tips and tricks to other clinicians. The aim is for a single arm, multicenter, retrospective analysis of patients in whom (ALI) was performed with the Penumbra/Indigo System (study device), and gather greater data and information than the PRISM trial in 2013-2014 which obtained only 79 patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lower Limb Ischemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Acute or Chronic clot

If chronic clot, no intervention given via Indigo

Group Type OTHER

'Indigo' Mechanical thrombectomy system

Intervention Type DEVICE

Removal of acute clot from the artery causing ischaemia, using the mechanical aspiration system by Penumbra Inc called "INDIGO"

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

'Indigo' Mechanical thrombectomy system

Removal of acute clot from the artery causing ischaemia, using the mechanical aspiration system by Penumbra Inc called "INDIGO"

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute lower limb Ischaemia with acute soft clot.

Exclusion Criteria

* Calcified plaques/ chronic disease causing critical limb Ischaemia
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

St. Franziskus Hospital

OTHER

Sponsor Role collaborator

Lancashire Care NHS Foundation Trust

NETWORK

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bella Huasen

Endovascular Interventional Consultant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bella Huasen, MD

Role: STUDY_CHAIR

Lancashire NHS

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Interventional Radiology

Preston, Lancashire, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bella Huasen, MD

Role: CONTACT

Phone: 00447871800565

Email: [email protected]

Theo Bisdas, Phd, MD

Role: CONTACT

Phone: 00492519355829

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

BELLA HUASEN, MD

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Karnabatidis D, Spiliopoulos S, Tsetis D, Siablis D. Quality improvement guidelines for percutaneous catheter-directed intra-arterial thrombolysis and mechanical thrombectomy for acute lower-limb ischemia. Cardiovasc Intervent Radiol. 2011 Dec;34(6):1123-36. doi: 10.1007/s00270-011-0258-z. Epub 2011 Sep 1.

Reference Type RESULT
PMID: 21882081 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Indigo2017

Identifier Type: -

Identifier Source: org_study_id